# Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study

> **NCT00309283** · PHASE3 · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 78 (actual)

## Conditions studied

- Autosomal Dominant Polycystic Kidney Disease (ADPKD)

## Interventions

- **DRUG:** Long-acting somatostatin
- **OTHER:** Saline solution

## Key facts

- **NCT ID:** NCT00309283
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2013-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00309283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00309283, "Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00309283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*